Neuroimaging of giant cell arteritis
https://doi.org/10.64265/3033-649X-2026.2.2.52-59
Abstract
Giant cell arteritis (GCA), previously known as temporal arteritis, is a chronic immunemediated infl ammatory disease with acute onset, representing the most common form of systemic vasculitis in patients over 50 years of age. The disease signifi cantly impacts quality of life and can lead to severe complications, including irreversible vision loss. Due to the diagnostic complexity of GCA and the need for morphological verifi cation of the diagnosis, the use of radiological imaging methods is of particular importance. The application of a standardized, unifi ed MRI protocol improves diagnostic accuracy, confi rms the clinical diagnosis, and provides navigation for biopsy of the aff ected arterial segment.
About the Authors
P. I. Trukhachev
Federal Neurosurgical Center
Russian Federation
Russian Federation
Pavel I. Trukhachev – Radiologist
Nemirovicha-Danchenko str., 132/1, Novosibirsk, 630087
V. D. Shmaenkova
Novosibirsk National Research State University
Russian Federation
Russian Federation
Viktoria D. Shmaenkova – Clinical Resident at the Center for Postgraduate Medical Education, Institute of Medicine and Medical Technologies
Pirogova str., 2, Novosibirsk, 630090
E. A. Filimonova
Federal Neurosurgical Center; Novosibirsk State Medical University
Russian Federation
Russian Federation
Elena A. Filimonova – Radiologist, Head of the Department of Radiology; Teaching Assistant at the Department of Neurosurgery
Nemirovicha-Danchenko str., 132/1, Novosibirsk, 630087
Krasny ave., 52, Novosibirsk, 630091
References
1. Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M. High-resolution MRI in giant cell arteritis: Imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol. 2005; 184(1): 283-287. https://doi.org/10.2214/ajr.184.1.01840283
2. Bley TA, Uhl M, Carew J, Markl M, Schmidt D, Peter HH, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007; 28(9): 1722-1727. https://doi.org/10.3174/ajnr.A0638
3. Bosch P, Dejaco C, Schmidt WA. Imaging in giant cell arteritis. Rheumatology (Oxford). 2023; 62(2): 593-602. https://doi.org/10.1093/rheumatology/keac496
4. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008; 372: 234-245. https://doi.org/10.1016/S0140-6736(08)61077-6
5. Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: Trend over 5 decades in a population-based cohort. J Rheumatol. 2015; 42(2): 309-315. https://doi.org/10.3899/jrheum.140188
6. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of Tocilizumab in giant-cell arteritis. N Engl J Med. 2017; 377(4): 317-328. https://doi.org/10.1056/NEJMoa1613849
7. Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024; 83(6): 741-751. https://doi.org/10.1136/ard-2023-224543
8. Bathla G, Agarwal AK, Messina SA, Black DF, Soni N, Diehn FE, et al. Imaging findings in giant cell arteritis: Don’t turn a blind eye to the obvious! AJNR Am J Neuroradiol. 2025; 46(3): 457-464. https://doi.org/10.3174/ajnr.A8388
9. Koster MJ, Matteson EL, Warrington KJ. Giant cell arteritis: Pathophysiology and clinical implications. Nat Rev Rheumatol. 2024; 20(1): 27-44. https://doi.org/10.1038/s41584-023-01027-10. Mamlouk MD, Chang PC, Saket RR. Contextual radiology reporting: A new approach
10. to neuroradiology structured templates. AJNR Am J Neuroradiol. 2018; 39(8): 1406-1414. https:// doi.org/10.3174/ajnr.A5697
11. Chaganti J, Warburton EA, Sarrami AH. Black blood imaging of intracranial vessel walls. Pract Neurol. 2021; 21(2): 101-108. https://doi.org/10.1136/practneurol-2020-002731
12. Mandell DM, Mossa-Basha M, Qiao Y, Hess CP, Hui F, Matouk C, et al.; Intracranial vessel wall MRI: Principles and expert consensus recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2017; 38(2): 218-229. https://doi.org/10.3174/ajnr.A4893
13. Nielsen BD, Hansen IT, Keller KK, Therkildsen P, Gormsen LC, Hauge EM. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference. Rheumatology (Oxford). 2021;60(2):e67–e68. https://doi.org/10.1093/rheumatology/keaa765
14. Gaddam DS, Crews G, Chryssikos T, Gandhi D, Morales R, Zhuo J, et al. Circumferential segmental vessel-wall enhancement on black blood MRI in patients referred for the evaluation of vasculopathy. Clin Imaging. 2021; 80: 67-71. https://doi.org/10.1016/j.clinimag.2021.05.024
15. Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022; 81(12): 1647-1653. https://doi.org/10.1136/ard-2022-223480
16. Rhee RL, Rebello R, Tamhankar MA, Banerjee S, Liu F, Cao Q, et al. Combined orbital and cranial vessel wall magnetic resonance imaging for the assessment of disease activity in giant cell arteritis. ACR Open Rheumatol. 2024; 6(4): 189-200. https://doi.org/10.1002/acr2.11649
17. Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, et al. Added value of vessel wall magnetic resonance imaging in the differentiation of Moyamoya vasculopathies in a non-Asian cohort. Stroke. 2016; 47(7): 1782-1788. https://doi.org/10.1161/STROKEAHA.116.013320
18. Monti S, Schäfer VS, Muratore F, Salvarani C, Montecucco C, Luqmani R. Updates on the diagnosis and monitoring of giant cell arteritis. Front Med (Lausanne). 2023; 10: 1125141. https://doi.org/10.3389/fmed.2023.1125141
19. Mossa-Basha M, Alexander M, Gaddikeri S, Yuan C, Gandhi D. Vessel wall imaging for intracranial vascular disease evaluation. J Neurointerv Surg. 2016; 8(11): 1154-1159. https://doi.org/10.1136/neurintsurg-2015-012127
20. Obusez EC, Hui F, Hajj-Ali RA, Cerejo R, Calabrese LH, Hammad T, et al. High-resolution MRI vessel wall imaging: Spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol. 2014; 35(8): 1527-1532. https://doi.org/10.3174/ajnr.A3909
21. Kang N, Qiao Y, Wasserman BA. Essentials for interpreting intracranial vessel wall MRI results: State of the art. Radiology. 2021; 300(3): 492-505. https://doi.org/10.1148/radiol.2021204096
22. Rhee RL, Bathla G, Rebello R, Kurtz RM, Junek M, Warrington KJ, et al. Vessel wall MRI in giant cell arteritis: Standardized protocol and scoring approach developed by an international working group. Rheumatology (Oxford). 2025; 64(5): 2910-2918. https://doi.org/10.1093/rheumatology/keae498
23. Mattay RR, Saucedo JF, Lehman VT, Xiao J, Obusez EC, Raymond SB, et al. Current clinical applications of intracranial vessel wall MR imaging. Semin Ultrasound CT MR. 2021; 42(5): 463-473. https://doi.org/10.1053/j.sult.2021.07.004
Review
For citations:
Trukhachev P.I., Shmaenkova V.D., Filimonova E.A. Neuroimaging of giant cell arteritis. Sibneuro. 2026;2(2):52-59. (In Russ.) https://doi.org/10.64265/3033-649X-2026.2.2.52-59
Views:
28
JATS XML
Email this article 